The potential impact of Taspase1 for neoplastic diseases extrapolated from its processing of leukemia inducing MLL fusion proteins containing a functional Taspase1 cleavage site is further supported by our identification of these substrates. The gene discussed is KMT2A; the disease is leukemia.